Day 1: Top Takeaways From ASCO24

Day 1: Top Takeaways From ASCO24

AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO)

Up next

'No Margin for Error': What to Know Before Implementing AI in Clinical Practice

Dr. Monty Pal and Dr. Arturo Loaiza-Bonilla discuss the institutional risks in the use of artificial intelligence (AI) in clinical practice and how overreliance on AI could erode essential skills. They also highlight practical approaches, including routine "AI-off" drills, to hel ...  Show more

 . 18min 20sec
Groundbreaking Results Shift Treatment Paradigm in High-Risk Smoldering Multiple Myeloma

Dr. Monty Pal speaks with internationally acclaimed hematologists Dr. Vincent Rajkumar and Dr. Saad Usmani about the AQUILA trial in high-risk smoldering multiple myeloma, as well as advances in CAR-T and other evolving treatment strategies in the myeloma space. TRANSCRIPT Dr. Mo ...  Show more

 . 19min 38sec

Recommended Episodes

Review of the GISSI-2 Trial
Cardiology Trials

Lancet 1990;336:65-71.

Background Large trials up to this point had established the role of thr ...

  Show more

 . 10min 3sec
Review of the MIRACL Trial
Cardiology Trials

JAMA 2001;285:1711-18.

Background Statin therapy had been shown to impr ...

  Show more

 . 11min 1sec
363. GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire
Cardionerds: A Cardiology Podcast

Welcome back to the CardioNerds Cardiovascular Prevention Series, where we are continuing our discussion of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs). This class of medications is becoming a household name, not only for their implications for weight loss but also for ...  Show more

 . 43min 1sec
Podcast 831: O2 Targets
Emergency Medical Minute

Contributor: Aaron Lessen,MD

Educational Pearls:

<ul> <li style="font-weight: 400;" aria-level="1"><span style= "font-weight: 400;">R</span><span style="font-weight: 400;">ecent study looked at mechanically ventilated patients in ED ...  Show more

 . 3min 19sec